Boothbay Fund Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1303 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1291 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1389 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1472 |
|
|
2022
Q2 | – | Sell |
-48,211
| Closed | -$79K | – | 2028 |
|
|
2022
Q1 | $79K | Hold |
48,211
| – | – | ﹤0.01% | 1751 |
|
|
2021
Q4 | $116K | Sell |
48,211
-27,463
| -36% | -$66.1K | ﹤0.01% | 1515 |
|
|
2021
Q3 | $366K | Buy |
75,674
+64,474
| +576% | +$312K | 0.01% | 1024 |
|
|
2021
Q2 | $30K | Hold |
11,200
| – | – | ﹤0.01% | 1627 |
|
|
2021
Q1 | $34K | Buy |
+11,200
| New | +$34K | ﹤0.01% | 1258 |
|